IDARUBICIN AND MELPHALAN AS MYELOABLATIVE REGIMEN AFTER SEQUENTIAL HIGH-DOSE CHEMOTHERAPY FOR LYMPHOMAS - PRELIMINARY-RESULTS OF A PHASE I-II STUDY WITH PHARMACOKINETIC GUIDED PERIPHERAL-BLOOD PROGENITOR-CELL REINFUSION

Citation
F. Peccatori et al., IDARUBICIN AND MELPHALAN AS MYELOABLATIVE REGIMEN AFTER SEQUENTIAL HIGH-DOSE CHEMOTHERAPY FOR LYMPHOMAS - PRELIMINARY-RESULTS OF A PHASE I-II STUDY WITH PHARMACOKINETIC GUIDED PERIPHERAL-BLOOD PROGENITOR-CELL REINFUSION, Blood, 90(10), 1997, pp. 4381-4381
Citations number
NO
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
90
Issue
10
Year of publication
1997
Part
2
Supplement
1
Pages
4381 - 4381
Database
ISI
SICI code
0006-4971(1997)90:10<4381:IAMAMR>2.0.ZU;2-6